| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crescent Biopharma, Inc. (CBIO) has 14 insiders with recent SEC Form 4 filings, including 7 buys and 10 sells. CBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.75M | $49.46M | - | |
| 10% | 707.1K | $12.73M | - | |
| CEO | 323.5K | $5.82M | - | |
| COO | 153.7K | $2.77M | - | |
| Other | 70.0K | $1.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | Fairmount Funds Management LLC73 | Director, 10% Owner | Buy | 1,360,000 | $13.41 | $18,237,600.00 | +98.0% | -11.5% | - | |
| Aug 8, 2024 | Invus Public Equities, L.P.78 | 10% Owner | Sell | 322,361 | $0.19 | $61,206.32 | -2.4% | +100.7% | -31.5% | |
| Aug 6, 2024 | Invus Public Equities, L.P.78 | 10% Owner | Sell | 220,255 | $0.19 | $41,183.94 | -1.6% | +128.8% | -38.6% | |
| Aug 2, 2024 | Invus Public Equities, L.P.78 | 10% Owner | Sell | 349,764 | $0.20 | $71,097.02 | -2.4% | +100.4% | -40.9% | |
| Jul 30, 2024 | Invus Public Equities, L.P.78 | 10% Owner | Sell | 1,379,119 | $0.23 | $315,261.62 | -5.5% | -22.8% | -42.2% | |
| Jun 21, 2024 | Rock Edwin45 | Chief Medical Officer | Buy | 305,000 | $0.26 | $78,824.50 | +32.4% | -33.9% | -41.7% | |
| Jun 18, 2024 | Hahn Brian M.47 | SVP Finance, CFO | Buy | 17,500 | $0.25 | $4,334.75 | +32.9% | -33.0% | -39.6% | |
| Sep 22, 2023 | Rock Edwin45 | Chief Medical Officer | Buy | 65,403 | $1.38 | $90,256.14 | +10.0% | +51.1% | -88.3% | |
| May 17, 2023 | Hahn Brian M.47 | SVP Finance, CFO | Sell | 3,700 | $1.95 | $7,215.00 | -6.5% | -21.6% | -86.2% | |
| May 10, 2023 | Junius Daniel M45 | Director | Buy | 30,000 | $1.56 | $46,800.00 | +47.4% | -8.0% | -83.1% |